Skip to main content
OpenTrials

Clinical trial condition

High-grade B-cell Lymphoma

Explore clinical trials studying High-grade B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

40 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

High-grade B-cell Lymphoma trial results

Active, not recruiting

A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)

NCT04914741

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
Locations
  • Concord Repatriation General Hospital Camperdown, New South Wales, Australia
  • St Vincent's Public Hospital Sydney Darlinghurst, New South Wales, Australia
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
View all 15 locations
View Trial Details
Active, not recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL

NCT03620578

Conditions
BCL-2 Translocation, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more
Locations
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Leuven-UZLEUVEN Leuven, Belgium
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almere-FLEVOZIEKENHUIS Almere Stad, Netherlands
View all 24 locations
View Trial Details
Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions
Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations
  • Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom
  • Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom
View Trial Details
Completed

A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

NCT03255096

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Weill Cornell Medical College New York, United States
  • Levine Cancer Institute - Blythe Charlotte, North Carolina, United States
View Trial Details

Related conditions